XL228
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for XL228, covering 2015-08-21 to 2015-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies [Phase 1]